 | Up a level |
Effatpanah, H. and Effatpanah, M. and Mohammadi, M.J. and Geravandi, S. and Ghadami, M. and Ahmadkhaniha, H. and Djavid, G.E. and Arabgol, F. (2020) Determination of association between the polymorphism in exon 3 of dopamine receptor gene type 4 with attention deficit-hyperactivity disorder. Clinical Epidemiology and Global Health, 8 (1). pp. 290-294.
Shalbafan, M. and Rashedi, V. and Seddigh, R. and Najarzadegan, M. and Azarpajouh, T. and Ahmadkhaniha, H. and Kamalzadeh, L. (2020) Validity and reliability of the Persian version of �drug-related knowledge and attitude questionnaire� among Iranian medical students. Journal of Addictive Diseases. pp. 1-6.
Ahmadkhaniha, H. and Mostafavi, H.A. and Nojoomi, M. and Parvizi-Emran, B. (2012) Age specific prevalence of metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics and control group. HealthMED, 6 (11). pp. 3680-3684.
Naserbakht, M. and Ahmadkhaniha, H. and Mokri, B. and Smith, C.L. (2011) Advanced paternal age is a risk factor for schizophrenia in Iranians. Annals of General Psychiatry, 10.
Ahmadkhaniha, H. and Tayebi, A. (2008) A case report of neuroleptic malignant syndrome induced by clozapine is neuroleptic malignant syndrome diagnostic criteria adequately sensitive to identify diverse features of the syndrome? Iranian Journal of Psychiatry and Behavioral Sciences, 2 (2). pp. 50-54.
